Hennekam lyphagectasia lyphedema syndrome

Reading File
Finding Sources
Searching PubMed

Hennekam lymphangiectasia lymphedema syndrome

Searching the Web

Hennekam lymphangiectasia lymphedema syndrome clinical features genetics

Reading File
Reading File
Reading Article
Reading File
Reading Web Page

Hennekam syndrome clinical features diagnosis treatment genetics

Searching Images

Hennekam syndrome lymphedema facial features

Here is a comprehensive overview of Hennekam Lymphangiectasia-Lymphedema Syndrome (HKLLS).

Hennekam Lymphangiectasia-Lymphedema Syndrome (HKLLS)

OMIM: #235510 (HKLLS1), #616006 (HKLLS2), #618154 (HKLLS3)

Overview

First described by Dutch physician R.C.M. Hennekam in 1989, HKLLS is a rare autosomal recessive disorder of generalized lymphatic dysplasia. Fewer than 50 cases were in the literature by early reports, though whole-exome sequencing is identifying more. It is classified among the primary (genetic) lymphedemas.

Genetics

Three causative genes have been identified, all disrupting the VEGFR3/VEGF-C signaling axis critical for lymphangiogenesis:
SubtypeGeneChromosomeMechanism
HKLLS1CCBE1 (collagen and calcium-binding EGF domains 1)18q21Reduces activation of VEGF-C → impairs VEGFR3 signaling
HKLLS2FAT4 (FAT atypical cadherin 4)4q28Planar cell polarity; overlaps with Van Maldergem syndrome-2
HKLLS3ADAMTS3 (a disintegrin and metalloproteinase with thrombospondin motifs 3)4q13Processes pro-VEGF-C → reduces VEGFR3 activity
A 2023 report identified FBXL7 as a potential novel fourth gene in HKLLS-like phenotypes. All known mutations impair lymphatic vessel formation before birth; since the lymphatic system is widespread, disruption affects multiple organs.

Clinical Features

1. Lymphatic Abnormalities (Core Features)

  • Intestinal lymphangiectasia — dilated lymphatic vessels of the gut → protein-losing enteropathy: low albumin, hypoproteinemia, immune deficiency (loss of lymphocytes and immunoglobulins)
  • Lymphedema — typically congenital or infantile onset; affects:
    • Lower extremities (most common)
    • Genitalia
    • Face (can be asymmetric — one side more severely affected)
  • Pericardial lymphangiectasia / pericardial effusion — recurrent, refractory (a 2025 case report highlights this as a diagnostic challenge even in middle-aged adults)
  • Pleural and pulmonary lymphangiectasia
  • Renal lymphangiectasia
  • Chylous ascites — accumulation of lymph fluid in the abdomen

2. Facial Dysmorphism (Characteristic)

  • Flat midface with depressed/broad nasal bridge
  • Hypertelorism (wide-set eyes)
  • Epicanthal folds, puffy/blepharoptotic eyelids (blepharophimosis)
  • Small mouth with gingival hypertrophy (gum overgrowth)
  • Low-set, small ears with narrow ear canals
  • Irregular dentition

3. Neurodevelopmental

  • Intellectual disability — variable, ranging from mild to severe (inconsistent; not always present)
  • Seizures
  • Growth delay / poor overall growth

4. Skeletal & Other

  • Craniosynostosis (premature skull fusion)
  • Camptodactyly (permanently bent fingers/toes)
  • Cutaneous syndactyly
  • Clubfeet
  • Pectus excavatum
  • Scoliosis
  • Hearing loss
  • Umbilical hernia
  • Structural anomalies of heart, kidneys, or genitals
  • Hirsutism

Differential Diagnosis

Key differentials in the setting of lymphedema + intellectual disability:
ConditionGeneDistinguishing Feature
Milroy diseaseVEGFR3, VEGF-CCongenital lower-limb lymphedema only; no intestinal involvement
Lymphedema-distichiasisFOXC2Extra eyelash row; no intellectual disability
MCLMR syndromeKIF11Microcephaly + chorioretinopathy
Hypotrichosis-lymphedema-telangiectasiaSOX18Hair loss + telangiectasia
Emberger syndromeGATA2Lymphedema + predisposition to AML
Van Maldergem syndromeFAT4Overlapping with HKLLS2

Diagnosis

Clinical diagnosis is based on the triad:
  1. Lymphangiectasia (especially intestinal)
  2. Lymphedema
  3. Facial dysmorphism ± intellectual disability
Laboratory:
  • ↓ Serum albumin, ↓ total protein (protein-losing enteropathy)
  • ↓ Lymphocytes, ↓ immunoglobulins
  • ↑ Stool α1-antitrypsin (marker of protein loss into gut)
Imaging:
  • MRI/CT lymphangiography: demonstrates dilated lymphatic channels
  • Endoscopy: white-tipped villi (intestinal lymphangiectasia) — note: biopsy may be normal even in proven cases
  • Echocardiography: pericardial effusion if suspected
Genetic confirmation:
  • Sequencing of CCBE1, FAT4, ADAMTS3 (also FOXC2, GJC2, KIF11 if negative)
  • Whole-exome sequencing is recommended if targeted panel is non-diagnostic (identifies novel variants)

Management

There is no curative therapy. Management is symptomatic and multidisciplinary:
ProblemIntervention
Intestinal lymphangiectasia / protein lossLow-fat diet with medium-chain triglycerides (MCTs bypass lymphatics); high-protein supplementation
LymphedemaComplete decongestive therapy (CDT): manual lymphatic drainage, compression garments, skin care
Pericardial effusionDrainage if symptomatic; treat underlying lymphatic cause
Pleural effusionDrainage; octreotide may reduce lymph flow
SeizuresStandard anticonvulsants
Intellectual disabilityEarly developmental intervention, special education
Immune deficiencyIVIG replacement if severely low immunoglobulins; infection prophylaxis

Prognosis

Prognosis depends on severity of protein-losing enteropathy and degree of lymphedema. Intestinal lymphangiectasia leading to severe hypoproteinemia and immunodeficiency is the major source of morbidity. Recurrent pericardial or pleural effusions can be life-threatening if unrecognized.

Key References

  • Fitzpatrick's Dermatology, 9th ed. — lymphatic malformation genetics table; HKLLS gene classification
  • Harrison's Principles of Internal Medicine, 22e (2025) — listed among genetic primary lymphedemas (CCBE1 gene)
  • Zhang R et al. (2025). Recurrent pericardial effusion due to Hennekam lymphangiectasia-lymphedema syndrome. BMC Cardiovasc Disord [PMID: 40394495] — highlights whole-exome sequencing for refractory pericardial effusion
  • MedlinePlus Genetics – Hennekam syndrome — comprehensive gene/mechanism summary
This is a shared conversation. Sign in to Orris to start your own chat.